CLPT
Clearpoint Neuro Inc
NASDAQ: CLPT · HEALTHCARE · MEDICAL DEVICES
$11.18
+8.12% today
Updated 2026-04-30
Market cap
$353.24M
P/E ratio
—
P/S ratio
9.55x
EPS (TTM)
$-0.90
Dividend yield
—
52W range
$8 – $30
Volume
0.8M
Clearpoint Neuro Inc (CLPT) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.67M | $3.82M | $5.06M | $3.93M | $3.60M | $4.59M | $5.75M | $7.38M | $7.35M | $11.22M | $12.83M | $16.30M | $20.55M | $23.95M | $31.39M | $36.97M |
| Revenue growth (YoY) | — | +43.0% | +32.5% | -22.3% | -8.3% | +27.5% | +25.1% | +28.4% | -0.4% | +52.5% | +14.4% | +27.0% | +26.1% | +16.6% | +31.0% | +17.8% |
| Cost of revenue | $16314.00 | $656414.00 | $555703.00 | $1.42M | $1.93M | $1.99M | $2.64M | $2.90M | $2.43M | $3.94M | $3.71M | $5.18M | $7.02M | $10.34M | $12.27M | $14.28M |
| Gross profit | $2.65M | $3.16M | $4.50M | $2.51M | $1.68M | $2.61M | $3.11M | $4.48M | $4.92M | $7.28M | $9.12M | $11.12M | $13.53M | $13.61M | $19.12M | $22.69M |
| Gross margin | 99.4% | 82.8% | 89.0% | 63.8% | 46.5% | 56.7% | 54.0% | 60.7% | 66.9% | 64.9% | 71.1% | 68.2% | 65.8% | 56.8% | 60.9% | 61.4% |
| R&D | $5.68M | $4.25M | $1.60M | $2.92M | $3.30M | $1.96M | $2.63M | $2.81M | $2.31M | $2.81M | $4.69M | $9.28M | $10.89M | $11.71M | $12.39M | $13.90M |
| SG&A | $4.70M | $4.83M | $6.03M | $7.06M | $8.04M | $8.37M | $4.19M | $4.05M | $4.33M | $4.30M | $5.27M | $8.00M | $9.61M | $11.76M | $12.00M | $16.50M |
| Operating income | $-9.52M | $-5.92M | $-3.13M | $-7.47M | $-5.32M | $-8.97M | $-7.49M | $-6.34M | $-5.25M | $-4.59M | $-6.22M | $-13.37M | $-16.33M | $-22.45M | $-19.75M | $-24.16M |
| Operating margin | -356.5% | -155.1% | -61.9% | -190.2% | -147.6% | -195.3% | -130.3% | -85.9% | -71.4% | -41.0% | -48.5% | -82.1% | -79.5% | -93.7% | -62.9% | -65.4% |
| EBITDA | $-7.60M | $-5.46M | $-2.70M | $-6.16M | $-3.13M | $-6.97M | $-6.85M | $-6.18M | $-5.07M | $-4.33M | $-4.79M | $-12.74M | $-15.58M | $-20.99M | $-17.84M | $-21.93M |
| EBITDA margin | -284.6% | -143.0% | -53.3% | -156.7% | -86.8% | -151.8% | -119.2% | -83.7% | -69.0% | -38.6% | -37.3% | -78.2% | -75.8% | -87.6% | -56.8% | -59.3% |
| EBIT | $-7.86M | $-5.81M | $-3.11M | $-6.59M | $-3.51M | $-7.19M | $-7.01M | $-6.29M | $-5.18M | $-4.58M | $-5.34M | $-13.44M | $-16.35M | $-22.45M | $-19.75M | $-24.16M |
| Interest expense | $1.59M | $2.50M | $2.58M | $499839.00 | $1.02M | $1.26M | $1.06M | $872926.00 | $980383.00 | $955000.00 | $1.44M | $973000.00 | $81000.00 | $386000.00 | $518000.00 | $2.39M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-9.45M | $-8.31M | $-5.71M | $-7.09M | $-4.52M | $-8.45M | $-8.07M | $-7.17M | $-6.16M | $-5.54M | $-6.78M | $-14.41M | $-16.43M | $-22.09M | $-18.91M | $-25.54M |
| Net income growth (YoY) | — | +12.1% | +31.3% | -24.2% | +36.1% | -86.7% | +4.5% | +11.2% | +14.0% | +10.1% | -22.4% | -112.5% | -14.1% | -34.4% | +14.4% | -35.0% |
| Profit margin | -354.2% | -217.7% | -112.8% | -180.3% | -125.5% | -183.9% | -140.4% | -97.1% | -83.8% | -49.4% | -52.9% | -88.4% | -80.0% | -92.2% | -60.3% | -69.1% |